查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1435063

抗焦慮藥物市場：按類型、劑型、給藥途徑、適應症、分銷管道 - 全球預測 2024-2030

Anxiolytics Market by Type (Antidepressants, Antihistamines, Azapirones), Form (Capsules, Tablets), Route of Administration, Indication, Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年抗焦慮藥物市場規模為12.4億美元，預計2024年將達13.2億美元，2030年將達20.3億美元，複合年成長率為7.27%。

全球抗焦慮藥物市場

主要市場統計
基準年[2023] 12.4億美元
預測年份 [2024] 13.2億美元
預測年份 [2030] 20.3億美元
複合年成長率（%） 7.27%
抗焦慮藥物市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估抗焦慮藥物市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對抗焦慮藥物市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-抗焦慮藥市場規模與預測是多少？

2-抗焦慮藥物市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-抗焦慮藥物市場的技術趨勢和法律規範是什麼？

4-抗焦慮藥市場主要供應商的市場佔有率是多少？

5-進入抗焦慮藥物市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人們焦慮症的盛行率以及心理健康和治療的意識增加
      • 抗焦慮藥物作為麻醉鎮靜劑的出現
    • 抑制因素
      • 長期使用抗焦慮藥物後的副作用相關問題
    • 機會
      • 醫藥領域抗焦慮藥物的技術進展
      • 政府加強促進心理健康和福祉
    • 任務
      • 與精神障礙相關的社會恥辱相關問題
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章抗焦慮藥物市場：依類型

  • 抗憂鬱症
  • 抗組織胺藥
  • 阿札匹隆
  • 苯二氮平類
  • BETA受體阻斷劑
  • 非苯二氮平類藥物
  • 鎮靜催眠

第7章抗焦慮藥物市場：依型態

  • 膠囊
  • 藥片

第8章焦慮藥物市場：依給藥途徑

  • 口服
  • 胃腸外的

第9章 抗焦慮藥物適應症市場

  • 整體焦慮症
  • 恐慌症
  • 恐懼症
  • 創傷後壓力症候群（PTSD）

第10章抗焦慮藥市場：依通路分類

  • 離線
  • 線上的

第11章美洲抗焦慮藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太焦慮藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章 歐洲、中東和非洲抗焦慮藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第15章競爭產品組合

  • 主要公司簡介
    • AbbVie Inc.
    • Accord Healthcare US
    • Akorn Operating Company LLC
    • Alvogen
    • Amneal Pharmaceuticals LLC
    • Apotex Inc.
    • AstraZeneca PLC
    • Bausch Health Companies Inc.
    • Dellwich Healthcare LLP
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline PLC
    • H. Lundbeck A/S
    • Hameln Pharma GmbH
    • Hikma Pharmaceuticals PLC
    • Johnson & Johnson Services, Inc.
    • Lifecare Neuro Products Limited
    • Lifegenix
    • Neurocon Inc.
    • Noreva Biotech
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
  • 主要產品系列

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-C002B1C994B7

[181 Pages Report] The Anxiolytics Market size was estimated at USD 1.24 billion in 2023 and expected to reach USD 1.32 billion in 2024, at a CAGR 7.27% to reach USD 2.03 billion by 2030.

Global Anxiolytics Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.24 billion
Estimated Year [2024] USD 1.32 billion
Forecast Year [2030] USD 2.03 billion
CAGR (%) 7.27%
Anxiolytics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anxiolytics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anxiolytics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anxiolytics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accord Healthcare US, Akorn Operating Company LLC, Alvogen, Amneal Pharmaceuticals LLC, Apotex Inc., AstraZeneca PLC, Bausch Health Companies Inc., Dellwich Healthcare LLP, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, H. Lundbeck A/S, Hameln Pharma GmbH, Hikma Pharmaceuticals PLC, Johnson & Johnson Services, Inc., Lifecare Neuro Products Limited, Lifegenix, Neurocon Inc., Noreva Biotech, Novartis AG, Pfizer Inc., Sanofi S.A., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Anxiolytics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Antidepressants
    • Antihistamines
    • Azapirones
    • Benzodiazepines
    • Beta-blockers
    • Nonbenzodiazepines
    • Sedative-hypnotics
  • Form
    • Capsules
    • Tablets
  • Route of Administration
    • Oral
    • Parenteral
  • Indication
    • Generalized Anxiety Disorder
    • Panic Disorder
    • Phobias
    • Posttraumatic Stress Disorder (PTSD)
  • Distribution Channel
    • Offline
    • Online
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Anxiolytics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anxiolytics Market?

3. What are the technology trends and regulatory frameworks in the Anxiolytics Market?

4. What is the market share of the leading vendors in the Anxiolytics Market?

5. Which modes and strategic moves are suitable for entering the Anxiolytics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Anxiolytics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of anxiety disorders among people and awareness about mental health and treatment
      • 5.1.1.2. Emergence of anxiolytics as sedative agents in anesthesia
    • 5.1.2. Restraints
      • 5.1.2.1. Problems associated with side effects after prolonged use of anxiolytics
    • 5.1.3. Opportunities
      • 5.1.3.1. Technical advancement of anxiolytic drugs in pharmaceutical sector
      • 5.1.3.2. Increasing government initiatives to promote mental health and wellbeing
    • 5.1.4. Challenges
      • 5.1.4.1. Problems related to social-stigma associated with mental disorders
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Anxiolytics Market, by Type

  • 6.1. Introduction
  • 6.2. Antidepressants
  • 6.3. Antihistamines
  • 6.4. Azapirones
  • 6.5. Benzodiazepines
  • 6.6. Beta-blockers
  • 6.7. Nonbenzodiazepines
  • 6.8. Sedative-hypnotics

7. Anxiolytics Market, by Form

  • 7.1. Introduction
  • 7.2. Capsules
  • 7.3. Tablets

8. Anxiolytics Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Oral
  • 8.3. Parenteral

9. Anxiolytics Market, by Indication

  • 9.1. Introduction
  • 9.2. Generalized Anxiety Disorder
  • 9.3. Panic Disorder
  • 9.4. Phobias
  • 9.5. Posttraumatic Stress Disorder (PTSD)

10. Anxiolytics Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Americas Anxiolytics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Anxiolytics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Anxiolytics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. AbbVie Inc.
    • 15.1.2. Accord Healthcare US
    • 15.1.3. Akorn Operating Company LLC
    • 15.1.4. Alvogen
    • 15.1.5. Amneal Pharmaceuticals LLC
    • 15.1.6. Apotex Inc.
    • 15.1.7. AstraZeneca PLC
    • 15.1.8. Bausch Health Companies Inc.
    • 15.1.9. Dellwich Healthcare LLP
    • 15.1.10. Eli Lilly and Company
    • 15.1.11. F. Hoffmann-La Roche Ltd.
    • 15.1.12. GlaxoSmithKline PLC
    • 15.1.13. H. Lundbeck A/S
    • 15.1.14. Hameln Pharma GmbH
    • 15.1.15. Hikma Pharmaceuticals PLC
    • 15.1.16. Johnson & Johnson Services, Inc.
    • 15.1.17. Lifecare Neuro Products Limited
    • 15.1.18. Lifegenix
    • 15.1.19. Neurocon Inc.
    • 15.1.20. Noreva Biotech
    • 15.1.21. Novartis AG
    • 15.1.22. Pfizer Inc.
    • 15.1.23. Sanofi S.A.
    • 15.1.24. Sun Pharmaceutical Industries Ltd.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. ANXIOLYTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ANXIOLYTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ANXIOLYTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANXIOLYTICS MARKET DYNAMICS
  • FIGURE 7. ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. ANXIOLYTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 10. ANXIOLYTICS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 12. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ANXIOLYTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ANXIOLYTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANXIOLYTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. ANXIOLYTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANXIOLYTICS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANXIOLYTICS MARKET SIZE, BY AZAPIRONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANXIOLYTICS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANXIOLYTICS MARKET SIZE, BY BETA-BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ANXIOLYTICS MARKET SIZE, BY NONBENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANXIOLYTICS MARKET SIZE, BY SEDATIVE-HYPNOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 14. ANXIOLYTICS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANXIOLYTICS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. ANXIOLYTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANXIOLYTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 20. ANXIOLYTICS MARKET SIZE, BY GENERALIZED ANXIETY DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ANXIOLYTICS MARKET SIZE, BY PANIC DISORDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ANXIOLYTICS MARKET SIZE, BY PHOBIAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ANXIOLYTICS MARKET SIZE, BY POSTTRAUMATIC STRESS DISORDER (PTSD), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. ANXIOLYTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. ANXIOLYTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ANXIOLYTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ANXIOLYTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ANXIOLYTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 236. ANXIOLYTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 237. ANXIOLYTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. ANXIOLYTICS MARKET LICENSE & PRICING